Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA03 - Predicting Outcomes in Patients with Early Disease NSCLC

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • +

      MA03.09 - Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.

      12:37 - 12:42  |  Presenter: Nienke Wolfhagen

      • Abstract

      Loading...

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-009 - A Clinical Outcome Comparison of IMRT and VMAT in Stage II and III NSCLC Irradiated with Radical Intent

      Presenter: Jose Belderbos

      • Abstract

      Loading...

    • +

      EP05.01-010 - External Validation of Two Prediction Models for Severe Radiation-induced Lymphopenia during Concurrent Chemoradiotherapy for Lung Cancer

      Presenter: Jose Belderbos

      • Abstract

      Loading...

  • +

    OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines

    • 11:00 - 12:10
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      OA06.05 - Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands

      11:22 - 11:32  |  Presenter: Nienke Wolfhagen

      • Abstract

      Loading...

  • +

    ES23 - Optimizing Radio-Chemo-Immunotherapy for Locally Advanced NSCLC

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      Session Moderator

      15:35 - 15:45  |  Presenter: Billy W Loo

      • Abstract

      Loading...

    • +

      Session Moderator

      15:35 - 15:45  |  Presenter: Jose Belderbos

      • Abstract

      Loading...

    • +

      ES23.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Billy W Loo

      • Abstract

      Loading...

    • +

      ES23.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Jose Belderbos

      • Abstract

      Loading...

    • +

      ES23.03 - Early Integration of Immune Checkpoint Inhibition into Radio-Chemotherapy

      14:47 - 14:59  |  Presenter: Willemijn S.M.E. Theelen

      • Abstract

      Loading...

    • +

      ES23.04 - Management of Patients with Oncogenic Driver Mutations

      14:59 - 15:11  |  Presenter: Ross Soo

      • Abstract

      Loading...

    • +

      ES23.05 - Next-Generation Radiotherapy in the Era of Immunotherapy

      15:11 - 15:23  |  Presenter: Ken Harada

      • Abstract

      Loading...

    • +

      ES23.06 - Diagnosis and Management of Pneumonitis after Radio-Chemo-Immunotherapy

      15:23 - 15:35  |  Presenter: Alexander Louie

      • Abstract

      Loading...

    • +

      ES23.07 - Live Q&A

      15:35 - 15:45

      • Abstract

      Loading...